FNY Investment Advisers LLC Buys Shares of 2,000 Tempus AI, Inc. (NASDAQ:TEM)

FNY Investment Advisers LLC purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,000 shares of the company’s stock, valued at approximately $67,000.

A number of other hedge funds have also modified their holdings of TEM. First Horizon Advisors Inc. acquired a new position in Tempus AI in the 3rd quarter worth about $30,000. Vestor Capital LLC acquired a new position in Tempus AI during the third quarter worth $153,000. Stifel Financial Corp acquired a new position in shares of Tempus AI during the 3rd quarter valued at about $218,000. Sandia Investment Management LP bought a new position in shares of Tempus AI in the 2nd quarter valued at approximately $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new stake in Tempus AI in the 3rd quarter worth approximately $258,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Trading Up 9.7 %

NASDAQ TEM opened at $34.92 on Thursday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company’s 50-day simple moving average is $47.24 and its 200 day simple moving average is $47.17.

Insider Activity

In related news, Director David R. Epstein sold 620 shares of Tempus AI stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total transaction of $25,922.20. Following the completion of the transaction, the director now directly owns 27,894 shares of the company’s stock, valued at $1,166,248.14. This trade represents a 2.17 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bradley A. Keywell sold 395,800 shares of the company’s stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the sale, the insider now directly owns 16,164,449 shares in the company, valued at $694,263,084.55. This represents a 2.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 865,041 shares of company stock worth $35,917,673.

Wall Street Analysts Forecast Growth

TEM has been the topic of a number of recent analyst reports. Piper Sandler reissued a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Loop Capital decreased their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday. Needham & Company LLC reiterated a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a research note on Tuesday. Finally, Bank of America increased their target price on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $56.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.